Redx Pharma Plc engages in the discovery and development of proprietary, small molecule drugs to address areas of high, unmet medical need. The company was founded by Neil David Murray, Peter Jackson, Derek Lindsay, and Norman Molyneux on September 7, 2010 and is headquartered in Macclesfield, the United Kingdom.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company